Heme Oxygenase 2005 -- the 4th International Conference

血红素加氧酶2005——第四届国际会议

• 批准号: 7001754
• 负责人: FRITZ H BACH
• 金额: $ 1万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-07-15 至 2006-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7001754
• 关键词: heme oxygenase; meeting /conference /symposium; travel

DESCRIPTION (provided by applicant): This application requests funds to provide support for "Heme Oxygenase 2005 - the 4th International Conference" to be held from October 5-8, 2005. The conference will be held at the Park Plaza Hotel in Boston, Massachusetts. This hotel is widely used for conferences and has excellent facilities, including all facilities for disabled persons. The conference dates are October 6-9, 2005. The participants for the main part are investigators (MDs, PhDs, and students) active in the field. However, given publicity we will mount, we expect that individuals interested in the possible application of the products of HO-1 to clinical problems will also attend. Scientists and physicians currently not involved in investigations in heme oxygenase will hopefully also find the conference of interest. The attendees are from all parts of the world involved in biomedical and biological research including, in addition to the United States, Australia, China, Japan, Taiwan, Korea, England, France, Italy, Germany, Holland, Poland, India and others. The objective of this meeting is to provide a format for the exchange and integration of new information on the molecular and cell biology as well as pre-clinical and proposed clinical protocols being considered in the field. The proposed meeting will bring together basic scientists from a variety of disciplines to present and discuss the most recent information on heme oxygenase and the products of the degradation of heme by heme oxygenases: carbon monoxide (CO), Fe++ and biliverdin. This Conference will, as it has in the past, act as a major stimulus for international research into the nature and function of these substances and to the path to clinical application. The focus of the meeting will be on the involvement of the heme oxygenases in the cardiac, vascular, pulmonary and other organ systems as well as on organ transplantation. Lay Summary: The heme oxygenase system is important in maintaining normalcy in the body. It prevents certain responses of the body, like inflammation, from becoming too strong and becoming destructive. The parts of the system will likely be useful to treat a wide variety of human disorders.

描述（由申请人提供）： 该申请要求资金为2005年10月5日至8日举行的“血红素氧化酶2005-第四届国际会议”提供支持。该会议将在马萨诸塞州波士顿的公园广场酒店举行。该酒店广泛用于会议，并拥有出色的设施，包括所有用于残疾人的设施。会议日期为2005年10月6日至9日。主要部分的参与者是活跃于该领域的调查人员（MDS，PHD和学生）。但是，鉴于我们将进行宣传，我们希望对HO-1产品可能应用于临床问题的个人感兴趣的人也将参加。目前未参与血红素加氧酶调查的科学家和医生也有望找到感兴趣的会议。与会者来自世界各地参与生物医学和生物学研究，包括美国，澳大利亚，中国，日本，台湾，韩国，英国，法国，意大利，德国，荷兰，波兰，印度，印度等。 这次会议的目的是为有关分子和细胞生物学的新信息以及该领域中考虑的临床前和拟议的临床方案的新信息提供一种格式。拟议的会议将从各个学科中汇集基本科学家，以介绍和讨论有关血红素氧化酶的血红素加氧酶以及血红素氧酶降解产物的最新信息：一氧化碳（CO），FE ++和胆汁丁物。与过去一样，这次会议将成为对这些物质的性质和功能以及临床应用道路的国际研究的主要刺激。 会议的重点将是血红素氧酶参与心脏，血管，肺和其他器官系统以及器官移植。介绍摘要：血红素加氧酶系统对于保持体内正常水平很重要。它可以防止身体的某些反应，例如炎症，变得太强壮并变得破坏性。系统的部分可能对治疗多种人类疾病有用。